The official blog of the Lung Institute.

This Week in Lung Disease: Wildfires Continue in California

31 Jul 2016
| Under Lifestyle | Posted by | 4 Comments
lung disease news

The internet is a big place and sometimes it can be difficult to find the news about the things that concern you. That’s why each week, the Lung Institute searches the internet to find the latest lung disease news. That way, you don’t have to waste time and can focus on your family and health.

Wildfires Continue in California

Brush fires in the Santa Clarita Valley have grown by more than 10,000 acres last weekend. The fires, happening in the mountains north of Los Angeles, have scored an estimated 33,172 acres. Mandatory evacuations have affected about 1,500 residents in nearby areas.

For those with chronic lung disease, wildfire smoke can be very hazardous. If a wildfire is happening in your region, make sure to follow the local news for air quality updates so you can be better prepared when leaving the house.

Read more about this story by going to the Los Angeles Times’ website.

Nearby Fracking May Worsen Symptoms of Asthma

A recent study conducted in Pennsylvania found that asthma for children and adults may have worsened for those living near fracking sites.

Fracking is a drilling technique for extracting oil and gas by injecting water and other materials into wells at high pressure to crack rocks. The environmental side effects of fracking have been a hot topic of debate in recent years. The study found that asthma treatments were up to four times more common for people living near bigger, more active wells than people who didn’t.

However, the study doesn’t say that fracking directly caused or worsened asthma.

To read more about this story, go to NBC News’ website.

Cellular Therapy Trial Suggests Hope for Those with Heart Disease

A recent small-scale study suggests damaged heart tissue could be regenerated thought a cellular therapy during heart surgery. The study, published in the Journal of Cardiovascular Translational Research, included 11 patients who received a cellular injection into their hearts during a bypass.

Another notable finding was a 40 percent reduction in the size of scarred tissue. Previous to this study, it was thought that scarred tissue in the lungs was irreversible. More research is needed.

To find out more about this story, go to The Guardian.

Hip Replacements Could Be Thing of the Past Due to Cells

Scientists have been trying new methods of growing new joint cartilage in an effort to change the way we treat damaged joints. This research, being conducted at the Washington University School of Medicine in St. Louis, looks to be a major step toward being able to use a patient’s own cells to repair joint injuries and do away with joint replacement surgeries. Scientists coaxed cells to grow new cartilage on a scaffold shaped like the ball of a hip joint.

For more information, go to Live Science.

Keep checking in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in cellular therapies for those with lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or cellular therapy, please contact one of our patient coordinators by calling 888-745-6697 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.